Scandonest 3% Plain — Class III drug recall D-0127-2021
Terminated recall by Novocol Pharmaceutical of Canada, Inc., reported 2020-12-16, distributed nationwide. Labeling: Label mix-up
| Recall number | D-0127-2021 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Novocol Pharmaceutical of Canada, Inc., Cambridge, N/A, Canada |
| Recall initiated | 2020-11-20 |
| Classified | 2020-12-09 |
| Reported by FDA | 2020-12-16 |
| Terminated | 2021-05-13 |
| Distributed | Nationwide (US) |
| Quantity | 15,398 cartridges |
| Reason classes | labeling |
| NDC | 00362-1098, 00362-1098-90 |
| Lot numbers | D02701G, D02766E, D02865C, D02894G, D02983D, D03032F, D03050E |
| Expiration dates | 2021-01-31, 2021-04-30, 2021-08-31, 2021-09-30, 2021-11-30, 2022-02-28 |
Product
Scandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50 cartridges (1.7 mL each), Rx only, Manufactured for SEPTODONT, Inc., Louisville, CO 80027, by Novocol Pharmaceutical of Canada, Inc., Cambridge, ON N1R 6X3, Canada, NDC 0362-1098-90
Reason for recall
Labeling: Label mix-up
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0127-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.